We still have no idea what illness she had, but her pediatrician's treatment, based on COVID-19 guidelines, made no sense.

The Center for Disease Control has released an update on how new prevention efforts are being made based off of new COVID-19 ...

— Recommendations are independently chosen by Reviewed's editors. Purchases made through the links below may earn us and our publishing partners a commission. Health officials for the Centers ...

Making sure you’re up to date with your COVID vaccine is important, Russo says. If you’re considered high risk for severe ...

Human metapneumovirus (HMPV) is garnering attention due to rising cases in China and advisories in Indian states like ...

While cases are climbing in China, the situation is very different from what it was when Covid-19 emerged five years ago, ...

COVID-19 can trigger pericarditis ... is the only Food and Drug Administration (FDA)-approved therap y for the treatment of recurrent pericarditis and reduction in risk of recurrence in adults ...

The antimalarial drug was briefly touted as a possible treatment for the novel coronavirus at a time when little else was available. This early study was published just as countries were shutting ...

Compounds in cannabis have the potential to prevent and treat Covid-19, according to a review of ... in how children and adults respond to the treatment. They also noted that most studies ...

A scientific journal on Tuesday retracted the March 2020 study that introduced the world to hydroxychloroquine early in the COVID-19 pandemic – and confirmed that the attention was undeserved from the ...

They're calling it "silent" because the wave follows a long period of unusually low COVID activity this fall, so many people ...

The study includes an extended follow up of approximately five and a half months after treatment ends to evaluate endpoints associated with post-acute sequelae of COVID-19 (PASC, or long COVID).